• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

cancer drugs

BioNTech
Biotech

BioNTech makes £1B commitment to expand UK research, build HQ

Some five months after AstraZeneca scrapped an investment plan in its home country, the U.K. has found a fresh partner in mRNA specialist BioNTech.
Fraiser Kansteiner May 20, 2025 11:15am
3D rendering of chromosomes and circular extrachromosomal DNA

Drug shrinks tumors in mice by targeting extrachromosomal DNA

Nov 6, 2024 12:50pm
kidney cancer renal cell carcinoma tumor

Arcus drops promising data on HIF-2a candidate in kidney cancer

Oct 24, 2024 2:48pm
Cell division process

Volastra taps CSO as it looks to expand research horizons

Oct 16, 2024 7:00am
A 3D rendering of the COVID-19 virus SARS-CoV-2 Most of the virus particles are blue with a bright red one in the center

Infinity Pharma cancer drug stops COVID, MRSA damage in mice

Jul 9, 2024 7:00am
Pythagorean theorem

ASCO: It's back to the basics for cancer drug developers

Jun 5, 2024 10:55am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings